Elite Suppressor–Derived HIV-1 Envelope Glycoproteins Exhibit Reduced Entry Efficiency and Kinetics
Open Access
- 10 April 2009
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 5 (4) , e1000377
Abstract
Elite suppressors (ES) are a rare subset of HIV-1–infected individuals who are able to maintain HIV-1 viral loads below the limit of detection by ultra-sensitive clinical assays in the absence of antiretroviral therapy. Mechanism(s) responsible for this elite control are poorly understood but likely involve both host and viral factors. This study assesses ES plasma-derived envelope glycoprotein (env) fitness as a function of entry efficiency as a possible contributor to viral suppression. Fitness of virus entry was first evaluated using a novel inducible cell line with controlled surface expression levels of CD4 (receptor) and CCR5 (co-receptor). In the context of physiologic CCR5 and CD4 surface densities, ES envs exhibited significantly decreased entry efficiency relative to chronically infected viremic progressors. ES envs also demonstrated slow entry kinetics indicating the presence of virus with reduced entry fitness. Overall, ES env clones were less efficient at mediating entry than chronic progressor envs. Interestingly, acute infection envs exhibited an intermediate phenotypic pattern not distinctly different from ES or chronic progressor envs. These results imply that lower env fitness may be established early and may directly contribute to viral suppression in ES individuals. The majority of HIV-1–infected individuals experience high plasma viral loads and CD4+ T cells loss in the absence of antiretroviral therapy. However, a very rare and important subset of individuals termed elite suppressors is able to maintain HIV-1 plasma viral loads below the limit of viral detection in the absence of treatment. The reasons behind this ability to control the virus are poorly understood, but they likely involve both an effective host immune response against HIV-1 and factors related to the virus itself. Here, we analyze the function of the HIV-1 coat protein or envelope glycoprotein from a group of elite suppressors. HIV-1 envelope mediates entry into the host cell via interaction with the cellular receptors CD4 and CCR5. Envelopes from elite controllers interacted with these receptors inefficiently compared to those from individuals with detectable viral loads. These inefficient interactions by elite suppressor envelopes led to slow rates of entry into host cells. Envelopes from acutely infected individuals were not significantly different from elite suppressors or chronically infected individuals. These findings suggest that the decreased envelope efficiency may contribute to viral control in elite suppressors.Keywords
This publication has 56 references indexed in Scilit:
- Genetic Characterization of Human Immunodeficiency Virus Type 1 in Elite Controllers: Lack of Gross Genetic Defects or Common Amino Acid ChangesJournal of Virology, 2008
- Transmission of Human Immunodeficiency Virus Type 1 from a Patient Who Developed AIDS to an Elite SuppressorJournal of Virology, 2008
- Natural Variation in the V3 Crown of Human Immunodeficiency Virus Type 1 Affects Replicative Fitness and Entry Inhibitor SensitivityJournal of Virology, 2007
- Cell surface expression of CCR5 and other host factors influence the inhibition of HIV-1 infection of human lymphocytes by CCR5 ligandsVirology, 2007
- Isolation and Characterization of Replication-Competent Human Immunodeficiency Virus Type 1 from a Subset of Elite SuppressorsJournal of Virology, 2007
- Mechanisms of Gastrointestinal CD4+T-Cell Depletion during Acuteand Early Human Immunodeficiency Virus Type 1 InfectionJournal of Virology, 2007
- Rapid Reversion of Sequence Polymorphisms Dominates Early Human Immunodeficiency Virus Type 1 EvolutionJournal of Virology, 2007
- Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusionVirology, 2006
- Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentrationBiochemical and Biophysical Research Communications, 2006
- Maintenance of viral suppression in HIV-1–infected HLA-B*57+ elite suppressors despite CTL escape mutationsJournal of Experimental Medicine, 2006